Kindred Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €36.33M +890.7% -€20.35M -61.5% -56.0% +14 pp -€5.36M -87.0% -14.7% +11 pp
    €3.67M +116.5% -€52.89M +23.5% -1,442.4% +11 pp -€41.28M +54.0% -1,125.8% +4.6 pp
    €1.69M +∞% -€42.81M +60.9% -2,527.5% -25 pp -€26.81M +95.0% -1,582.7% -16 pp
    €0.00 +NaN% -€26.60M +37.2% N/A -€13.75M -10.5% N/A
    €0.00 +NaN% -€19.38M -17.1% N/A -€15.36M -19.1% N/A
    €0.00 +NaN% -€23.37M -0.0% N/A -€18.98M +2.5% N/A
    €0.00 +NaN% -€23.38M +544.1% N/A -€18.52M +1,279.3% N/A
    €0.00 +NaN% -€3.63M +3,411.2% N/A -€1.34M +2,413.4% N/A
    €0.00 -€103.39K N/A -€53.42K N/A

    Notifications